In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
Regenxbio Inc (NASDAQ: RGNX) closed the day trading at $1.17M up 2549429% from the previous closing price of $8.57. In other words, the price has increased by $2549429 from its previous closing price. On the day, 2.55 million shares were traded. RGNX stock price reached its highest trading level at $8.83 during the session, while it also had its lowest trading level at $8.16.
Ratios:
For a better understanding of RGNX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.93 and its Current Ratio is at 2.93. In the meantime, Its Debt-to-Equity ratio is 0.49 whereas as Long-Term Debt/Eq ratio is at 0.30.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on February 11, 2025, Downgraded its rating to Neutral and sets its target price to $14 from $38 previously.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 12 ’25 when Mills Kenneth T. sold 20,602 shares for $7.91 per share. The transaction valued at 163,046 led to the insider holds 475,103 shares of the business.
KENNETH MILLS bought 20,602 shares of RGNX for $154,927 on May 12 ’25. On Dec 30 ’24, another insider, VITTAL VASISTA, who serves as the Officer of the company, bought 20,041 shares for $7.41 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RGNX now has a Market Capitalization of 424776768 and an Enterprise Value of 288508768. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.71 while its Price-to-Book (P/B) ratio in mrq is 1.54. Its current Enterprise Value per Revenue stands at 1.841 whereas that against EBITDA is -2.041.
Stock Price History:
The Beta on a monthly basis for RGNX is 1.09, which has changed by -0.3408913 over the last 52 weeks, in comparison to a change of 0.09544468 over the same period for the S&P500. Over the past 52 weeks, RGNX has reached a high of $15.36, while it has fallen to a 52-week low of $5.03. The 50-Day Moving Average of the stock is -2.13%, while the 200-Day Moving Average is calculated to be -3.68%.
Shares Statistics:
Over the past 3-months, RGNX traded about 1.17M shares per day on average, while over the past 10 days, RGNX traded about 1134890 shares per day. A total of 50.12M shares are outstanding, with a floating share count of 45.66M. Insiders hold about 9.39% of the company’s shares, while institutions hold 87.17% stake in the company. Shares short for RGNX as of 1748563200 were 6020756 with a Short Ratio of 5.17, compared to 1745971200 on 5168219. Therefore, it implies a Short% of Shares Outstanding of 6020756 and a Short% of Float of 14.6.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
